SCALE-UP OF THE MANUFACTURING TECHNOLOGY FOR AN IODINE-BASED PHARMACEUTICAL POTENTIATOR WITH ANTIMICROBIAL ACTIVITY

Introduction.The growth of antibiotic resistance poses a threat to the global health system and is increasing interest in antimicrobial potentiators. Iodine-based compounds are characterized by low resistance to bacteria and a broad spectrum of action. For their use at the industrial level, it is important to scale up the technology and obtain a stable quality product.

Research objective. To conduct the process of scaling up an iodine-based antimicrobial pharmaceutical substance in pilot production conditions, optimize technological parameters and evaluate the quality and stability characteristics of the finished product.

Research materials and methods. The study was conducted in the pilot production and laboratories of the JSC « Scientific Center for Anti-Infective Drugs». A substance containing iodine, potassium iodide, starch, polyvinyl alcohol and neutral salts was prepared. Physicochemical analyses (pH, density, quantitative composition), microbiological purity and 12-month stability tests were conducted. Three production batches were prepared and the data were processed.

Results. The quality of the finished product met all regulatory requirements: iodine content 8.33–8.39 mg/ml, potassium iodide – 11.73-11.83 mg/ml, pH – 4.24-4.27, density – 1.062-1.063. Microbiological purity indicators fully comply with the requirements. During the study, important technological parameters were analyzed at the main stages of production (raw material measurement, mixing, hydrolysis, obtaining the finished product, quality control, packaging and labeling).

Conclusion. The results obtained during the scaling-up of an iodine-based antimicrobial substance are an important scientific and technological base that will allow this substance to be introduced into industrial production. The scaled-up technology allows for the production of high-quality, stable and safe products. As a result of scaling up from the laboratory level to the pilot production site, the critical parameters for the production of an iodine-based antimicrobial potentiator were identified and the technological conditions were optimized. The results obtained will serve as the basis for introducing the pharmaceutical substance into industrial production and will contribute to meeting its growing demand.

1. REFERENCES

2. Ding, D. The spread of antibiotic resistance to humans and potential protection strategies / D. Ding, B. Wang, X. Zhang, J. Zhang, H. Zhang, X. Liu, Z. Gao, Z. Yu // Ecotoxicology and Environmental Safety. – 2023. – Vol. 254. – Art. 114734. – DOI: https://doi.org/10.1016/j.ecoenv.2023.114734.

3. Abdulkadyrova, A. T. Antibiotikorezistentnost': issledovanie mehanizmov antibiotikorezistentnosti i poisk novyh podhodov k lecheniju / A. T. Abdulkadyrova, P. P. Jusuppaeva, F. S. Adzhieva // Nauchnyj forum : sb. st. IV Mezhdunar. nauch.-prakt. konf., Penza, 25 avg. 2023 g. – Penza : Nauka i prosveshhenie (IP Guljaev G. Ju.), 2023. – S. 134–136. – EDN YVAZXT.

4. Chawla, M. Antibiotic potentiators against multidrug-resistant bacteria: discovery, development, and clinical relevance / M. Chawla, J. Verma, R. Gupta, B. Das // Frontiers in Microbiology. – 2022. – Vol. 13. – Art. 887251. – DOI: 10.3389/fmicb.2022.887251. – PMID: 35847117. – PMCID: PMC9284026.

5. Paul, D. Antibiotic potentiation as a promising strategy to combat macrolide resistance in bacterial pathogens / D. Paul, M. Chawla, T. Ahrodia, L. Narendrakumar, B. Das // Antibiotics (Basel). – 2023. – Vol. 12, № 12. – Art. 1715. – DOI: 10.3390/antibiotics12121715. – PMID: 38136749. – PMCID: PMC10740890.

6. Nevezhina, A. V. Antimikrobnyj potencial jodsoderzhashhih veshhestv i materialov / A. V. Nevezhina, T. V. Fadeeva // Acta Biomedica Scientifica. – 2023. – T. 8, № 5. – S. 36–49. – DOI: https://doi.org/10.29413/ABS.2023-8.5.4.

7. Қazaқstan Respublikasy Densaulyқ saқtau ministrlіgі Medicinalyқ zhәne farmacevtikalyқ baқylau komitetі. «Dәrіlіk zattar men medicinalyқ bұjymdardy saraptau ұlttyқ ortalyғy» [Jelektrondyқ resurs]. URL: http://register.ndda.kz/category/search_prep (data obrashhenija: [10.12.2024]).

8. Almakaeva, L. G. Masshtabirovanie processa proizvodstva rastvora dlja in#ekcij na osnove meloksikama [Tekst] / L. G. Almakaeva, L. G. Naumenok, N. V. Begunova, V. G. Dolja, M. S. Almakaev // Vestnik farmacii. – 2017. – № 3 (77). – Rezhim dostupa: https://cyberleninka.ru/article/n/masshtabirovanie-protsessa-proizvodstva-rastvora-dlya-inektsiy-na-osnove-meloksikama (data obrashhenija: 15.07.2024).

9. Stadnichenko, A. V. Osobennosti transfera tehnologii i masshtabirovanija pri promyshlennom osvoenii proizvodstva liposomal'nyh citostatikov [Tekst] / A. V. Stadnichenko, Ju. M. Krasnopol'skij, T. G. Jarnyh // Upravlenie, jekonomika i obespechenie kachestva v farmacii. – 2018. – № 2 (54). – S. 23–28. – DOI: 10.24959/uekj.18.11. – EDN XRDYTZ.

10. Evrazijskaja jekonomicheskaja komissija. Rekomendacii. Rukovodstvo po transferu tehnologij i (ili) analiticheskih metodik pri proizvodstve lekarstvennyh sredstv: rekomendacija Kollegii Evrazijskoj jekonomicheskoj komissii ot 8 ijunja 2021 g. № 11. – [Jelektronnyj resurs]. – Rezhim dostupa: https://adilet.zan.kz/rus/docs/H21RK000011 (data obrashhenija: [10.12.2024]).

11. Waghmare, Y. The important role of technology transfer in pharmaceutical industry – a review / Y. Waghmare // World Journal of Pharmaceutical Research. – 2017. – Vol. 6, Issue 9. – P. 310–329. – DOI: 10.20959/wjpr20179-9271.

12. Sivadasan, S. An overview on technology transfer of pharmaceutical industry / S. Sivadasan, N. Karnan, B. Rajkumar, M. Subramanaian, S. Chelladurai, G. Arulkumaran, M. S. // International Journal of Pharmaceutical Sciences and Research. – 2020. – Vol. 11, No. 2. – P. 573–579. – DOI: 10.13040/IJPSR.0975-8232.11(2).573-79.

13. Adamenko, G. V. Transfer tehnologij i masshtabirovanie processa proizvodstva spirtosoderzhashhih lekarstvennyh sredstv dlja profilakticheskoj antiseptiki / G. V. Adamenko // Vestnik farmacii. – 2020. – № 1 (87). – S. 87–99.

14. Bachurina, A. V. Perenos tehnologii lekarstvennyh preparatov. Faktory obespechenija kachestva v processe zhiznennogo cikla / A. V. Bachurina, L. V. Shigarova // Innovacii v zdorov'e nacii : sb. materialov V Vseros. nauch.-prakt. konf. s mezhdunar. uchastiem, Sankt-Peterburg, 08–09 nojab. 2017 g. – SPb. : GBOU VPO SPbGHFA Minzdrava Rossii, 2017. – S. 107–109. – EDN OSUDSB.

15. Bandarapalle, K. A comprehensive review on pilot plant scale up and platform technology / K. Bandarapalle, R. K. Kumarachari, K. T. Sri, B. Neeraja, C. Likhitha, K. Chaitanya, C. Y. Bhargavi // Future Journal of Pharmaceuticals and Health Sciences. – 2024. – Vol. 4, No. 1. – P. 14–25. – DOI: https://doi.org/10.26452/fjphs.v4i1.549.

16. Uslovnye oboznachenija oborudovanija pri razrabotke apparaturnyh shem proizvodstva gotovyh lekarstvennyh sredstv [Jelektronnyj resurs] / sost. A.V. Basevich, E.M. Smirnova, K.A. Solov'ev. – Sankt-Peterburg: Izd-vo SPHFA, 2015.

17. Evrazijskaja jekonomicheskaja komissija. Rekomendacija: «O Rukovodstve po validacii processa proizvodstva lekarstvennyh sredstv dlja medicinskogo primenenija» / rekomendacija Kollegii Evrazijskoj jekonomicheskoj komissii № 19 ot 26 sentjabrja 2017 g.. – [Jelektronnyj resurs]. – Rezhim dostupa: https://adilet.zan.kz/rus/docs/H17RK000019 (data obrashhenija: [12.12.2024]).

18. Kazahstan. Ministerstvo zdravoohranenija. Prikazy. Ob utverzhdenii Pravil provedenija proizvoditelem lekarstvennogo sredstva issledovanija stabil'nosti, ustanovlenija sroka hranenija i povtornogo kontrolja lekarstvennyh sredstv: prikaz № ҚR DSM-165/2020 ot 28 oktjabrja 2020 g. / Ministerstvo zdravoohranenija Respubliki Kazahstan. – [Jelektronnyj resurs]. – Rezhim dostupa: https://adilet.zan.kz/rus/docs/V2000021545 (data obrashhenija: [15.12.2024]).